Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb
    However, several are new drugs, including promising candidates talazoparib for treating breast cancer, and diabetes drug ertugliflozin ... they believe are the 10 best stocks for investors to buy right now... and Pfizer wasn't one of them!
    09/16/2017 - 7:03 pm | View Link
  • AstraZeneca could buy Bristol stake in diabetes JV: analyst
    following a decision by the U.S. firm to exit diabetes drug research, according to Citi. Bristol said on Thursday it would no longer conduct research to discover new drugs for diabetes, hepatitis C and neuroscience, but will increase spending on medicines ...
    11/7/2013 - 9:40 pm | View Link
  • Bristol's acquisition of Amylin reflects trend in Big Pharma
    Bristol-Myers Squibb’s $5.3 billion deal to buy ... Amylin offered Bristol two products already approved for sale by U.S. regulators, the twice-daily diabetes injection Byetta, which generated $518 million in 2011, and a longer-acting form of that drug ...
    07/1/2012 - 10:47 pm | View Link
  • Bristol-Myers to acquire diabetes drug maker Amylin
    Amylin Pharmaceuticals Inc., the San Diego drug maker whose treatments include the diabetes therapies Bydureon and Byetta, will be acquired by Bristol-Myers Squibb Co. for $5.3 billion in cash. Bristol-Myers agreed to pay $31 a share for Amylin ...
    06/29/2012 - 1:00 pm | View Link
  • Bristol-Myers in Deal for Amylin Valued at $7 Billion
    Bristol-Myers Squibb agreed late on Friday to buy Amylin Pharmaceuticals, the maker of a promising new diabetes drug, in a complicated deal that is valued at about $7 billion. To help finance the transaction, Bristol-Myers is teaming up with AstraZeneca ...
    06/29/2012 - 11:29 am | View Link
  • More
  • Pharmaceuticals
    9:00 AM ET Wed, 18 Oct 2017. Anthem, which sued the pharmacy benefit manager last year over claims of being overcharged by $3 billion annually, said it would use drug ...
    10/21/2017 - 12:28 am | View Website
  • Buy Online Low Cost Pharmacy, Mexico Medicine Hub-MMDS
    Mmds enables you to purchase quality medicines from Mexico at prices that are typically 70% to 90% less than in the United States. MyMexicanDrugStore is a reliable ...
    10/20/2017 - 9:43 pm | View Website
  • Health
    Get the latest health news, diet & fitness information, medical research, health care trends and health issues that affect you and your family on
    10/20/2017 - 5:25 pm | View Website
  • FiercePharma
    Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.
    10/20/2017 - 10:09 am | View Website
  • FierceBiotech
    Newsletter with articles on current research finds, industry news, job listings and event schedules. Includes sign up form and information about the company.
    10/20/2017 - 9:26 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News